Impact Biomedical Cash Flow Statement (2022-2026) | IBO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.80M-2.24M-3.37M-0.85M-1.12M-1.18M-1.26M-1.00M-0.88M4.24M-27.10M-1.28M-14.35M-1.48M-2.28M
Depreciation and Depletion (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based Compensation (Quarter) 0.02M0.00M0.00M0.00M0.01M1.44M
Deferred Taxes (Quarter) -1.88M
Cash from Operations (Quarter) -0.80M-0.36M-1.01M-0.73M-0.67M-0.43M-0.48M-0.39M-1.00M-0.99M-0.68M-0.69M-0.61M0.10M-0.46M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.28M0.29M0.29M0.29M0.28M
Change in Working Capital
Change in Receivables (Quarter) 0.01M-0.01M-0.01M
Change in Inventory (Quarter) -0.00M-0.00M
Change in Account Payables (Quarter) -0.07M0.49M-0.35M0.12M0.17M0.36M0.19M-0.04M0.01M-0.60M-0.10M-0.06M0.02M0.61M0.03M
Change in Accured Expenses (Quarter) 0.01M0.05M-0.01M-0.05M0.01M0.22M-0.18M0.01M0.04M0.09M0.01M0.06M0.07M-0.14M0.02M
Other Working Capital Changes (Quarter) -0.03M0.04M0.08M-0.14M0.05M-0.10M0.00M0.04M0.32M-0.10M-0.10M-0.00M0.04M-0.06M-0.05M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.01M0.00M
Cash from Investing Activities (Quarter) -0.00M-0.28M-0.00M-0.01M-0.00M0.00M0.00M0.00M0.00M0.00M-0.00M
Financing Activities
Cash from Financing Activities (Quarter) 0.77M0.54M1.02M0.75M0.87M0.23M0.48M0.38M3.67M0.32M0.48M
Additional items
Change in Cash (Quarter) -0.03M-0.10M-0.00M0.00M0.20M-0.20M0.00M2.67M-0.67M-0.68M-0.69M-0.61M-0.01M0.02M
Free Cash Flow (Quarter) -0.80M-0.36M-1.02M-0.74M-0.67M-0.43M-0.48M-0.39M-1.00M-0.99M-0.68M-0.69M-0.61M0.10M-0.46M
Net Cash Flow (Quarter) -0.03M-0.10M-0.00M0.00M0.20M-0.20M0.00M-0.00M2.67M-0.67M-0.68M-0.69M-0.61M0.10M0.02M